Navigation Links
Now Available in South Florida: CentraSight Treatment Program Offers New Hope for Patients with End-Stage Macular Degeneration
Date:2/13/2013

FORT LAUDERDALE, Fla., Feb. 13, 2013 /PRNewswire/ -- The CentraSight™ treatment program, now available at Retina Associates of Miami in South Florida, features the first-ever FDA-approved telescope implant surgical option for patients with End-Stage Age-related Macular Degeneration (AMD), the most advanced form of AMD and the leading cause of blindness in older Americans.

(Photo: http://photos.prnewswire.com/prnh/20130213/LA59823)

Smaller than a pea, the telescope implant uses micro-optical technology to magnify images which would normally be seen in one's "straight ahead," or central, vision. The images are projected onto the healthy portion of the retina not affected by the disease.

The telescope implant has been demonstrated in clinical trials to improve quality of life for those with central vision loss in both eyes. It improves patients' vision and returns things most of us take for granted. People regain the ability to see the things that are important to them, increase their independence, and re-engage in everyday activities. They can once again recognize faces and see expressions.

The telescope implant is not a cure for end-stage AMD. As with any medical intervention, potential risks and complications exist with the telescope implant. Possible side effects include decreased vision or vision-impairing corneal swelling.

The first CentraSight Patient Treatment Program team in South Florida includes Dr. J. Harris Levy , MD, Dr. Rashid M. Taher , MD, and Wilfredo C. Lara , MD, who evaluate the patient's medical condition for eligibility certification; Dr. Jesse Pelletier , MD, who performs the implant surgery; and Dr. Marc J. Gannon , OD, FAOO, the low vision specialist who evaluates the patient's visual function and coordinates the post-surgical therapy.

To schedule an evaluation contact Dr. Marc Gannon at 866-942-2020.
Visit www.lowvisioninstitute.com for more information.

About CentraSight
CentraSight is the first-ever telescope implant for end-stage age-related macular degeneration (AMD), the most advanced form of AMD and the leading cause of blindness in older Americans.  Patients with end-stage AMD have a central blind spot or missing area in their vision that makes it difficult or impossible to see faces, read, and perform everyday activities. The CentraSight Treatment Program allows patients to see again by implanting a tiny telescope in the eye in an outpatient procedure, then coordinating with vision specialists to help the patient learn how to use their new vision for everyday activities. For more information visit http://www.centrasight.com/

About Macular Degeneration
More than 15 million Americans are affected by some form of AMD. This number is expected to double by the year 2050.

  • Patients who progress to the end-stage form of AMD have a central blind spot that makes it difficult or impossible for patients to perform everyday activities such as reading, watching TV, preparing meals, and self-care.
  • Macular degeneration attacks the macula, the region of the retina responsible for central, detailed vision. It robs the individual of their central, straight-ahead vision, resulting in what is often referred to as a central vision "blind spot." It does not affect the outer circle of peripheral vision. People see things to the side, but it is too blurry to make up for lost central vision.
  • First signs of AMD: straight lines may appear wavy or disconnected; when looking at a person's face, it is blurred while the rest of the person is in focus; lines of print may be blurred in the center or the lines may be crooked.

CONTACT: Jackie Goldstein
jackieflashgoldstein@gmail.com 
954.849.7971


'/>"/>
SOURCE Retina Associates of Miami
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Vasomedical, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
2. Aethlon Medical, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
3. Inovio Pharmaceuticals, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
4. Last Minute Batch of Flu Shots made Available for Free At Naperville and Arlington Heights Immediate Care Centers
5. Raleigh CoolSculpting Complete Provides Twice the Fat Elimination in Just One Hour Now Available at Michael Law MD Aesthetic Plastic Surgery
6. Phase 3 Topical Drug for Raynauds Disease Available for Licensing/Acquisition at the J.P. Morgan Conference
7. Now Available in Fredericksburg: Painless Screening Exam To Help Prevent Heart Attacks, Strokes
8. The First Lean Healthcare App is Now Available in Apples App Store
9. Fuse Science, Inc. DROPS Now Available at PoweredByFuse.com
10. Vicks Starry Night Humidifier Available Now in New Colors Exclusively at Babies"R"Us
11. New Treatment For Obstructive Sleep Apnea Now Available In Canada
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... and Markets has announced the addition of the "Vital Signs Monitoring ... Industry Forecast, 2014-2022" report to their offering. ... Vital signs monitoring market size was worth $3,694 ... growing at a CAGR of 5.8% from 2016 to 2022. ... in global vital signs monitoring devices industry. The blood pressure monitoring devices ...
(Date:1/18/2017)... SAN JOSE, Calif. , Jan. 18, 2017  Adaptive ... machines, announced today a new partnership with Hyatt Place ... guests by providing ASTI LectroFan sleep therapy machines in ... "Obviously one of the most important parts of having ... Wicks , general manager of Hyatt Place Nashville/Downtown. "We,re ...
(Date:1/18/2017)... LITTLE FALLS, N.J. , Jan. 18, 2017 /PRNewswire/ ... RGIN ), a biotechnology company specializing in the development ... health of damaged tissues and organs, recently reported the ... key milestones for 2017. As the Company ... 2016 has been a year of substantial accomplishments. The ...
Breaking Medicine Technology:
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... ... in a medical capacity this year. Drs. Alexander Paziotopoulos, Andrew Petersen and Trish ... a condensed version of the clinic’s leading recovery program. , “We know ...
(Date:1/19/2017)... ... 19, 2017 , ... Bio-Optronics Inc. is proud to announce ... designed to seamlessly integrate and streamline the way researchers prepare and conduct patient ... usability and improving efficiency significantly for users – a first in the CTMS ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... panel system. , The Tranquility privacy panel system was designed to deliver ... Tranquility panels help reduce noise and provide the visual privacy required to maintain ...
(Date:1/19/2017)... ... January 19, 2017 , ... Rountree ... planning services to communities throughout eastern Georgia, is embarking on a charity effort ... Heart disease kills more Americans every year than anything else, yet risk factors ...
(Date:1/19/2017)... , ... January 19, 2017 , ... Attorney Robert ... fifth consecutive year donated money to the Triumph Over Kid Cancer foundation. Each year, ... one of those children. James saw firsthand the effect of the critical funding gap ...
Breaking Medicine News(10 mins):